PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?

by Franzese, Elisena, Diana, Anna, Centonze, Sara, Pignata, Sandro, De Vita, Ferdinando, Ciardiello, Fortunato, Orditura, Michele
Published in Front Oncol (2020)

Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes

by Diana, Anna, Carlino, Francesca, Franzese, Elisena, Oikonomidou, Olga, Criscitiello, Carmen, De Vita, Ferdinando, Ciardiello, Fortunato, Orditura, Michele
Published in Cancers (Basel) (2020)

Genomic Profile and BRCA-1 Promoter Methylation Status in BRCA Mutated Ovarian Cancer: New Insights in Predictive Biomarkers of Olaparib Response

by Franzese, Elisena, Centonze, Sara, Diana, Anna, Lombardi, Angela, Carlino, Francesca, Guerrera, Luigi Pio, De Vita, Ferdinando, Caraglia, Michele, Pignata, Sandro, Ciardiello, Fortunato, Orditura, Michele
Published in Front Oncol (2019)

Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells

by Morgillo, Floriana, Della Corte, Carminia Maria, Diana, Anna, Mauro, Concetta di, Ciaramella, Vincenza, Barra, Giusi, Belli, Valentina, Franzese, Elisena, Bianco, Roberto, Maiello, Evaristo, de Vita, Ferdinando, Ciardiello, Fortunato, Orditura, Michele
Published in Oncotarget (2017)

Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study

by Farolfi, Alberto, Scarpi, Emanuela, Greco, Filippo, Bergamini, Alice, Longo, Lucia, Pignata, Sandro, Casanova, Claudia, Cormio, Gennaro, Bologna, Alessandra, Orditura, Michele, Zavallone, Laura, Attademo, Laura, Gallà, Valentina, Franzese, Elisena, Pigozzi, Eva, Loizzi, Vera, Giorda, Giorgio, Giardina, Donatella, Cioffi, Raffaella, De Giorgi, Ugo
Published in Sci Rep (2020)